Deferasirox 67877-0549-30

Package NDC

67877-0549-30

Manufacturer: Ascend Laboratories, Llc
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 22, 2019
Listing Expires: December 31, 2026
Application: ANDA210519

Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Deferasirox	125 mg/1

Drug Class

Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]

Selected Package

67877-0549-30Selected

30 TABLET, FOR SUSPENSION in 1 BOTTLE (67877-549-30)